Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis

T. ARIGA, T. YOSHIDA, T. MIMORI, Robert K Yu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Sera from patients with Graves’ disease and Hashimoto's thyroiditis have been shown to react with the Forssman glycolipid antigen (Gb5) using the techniques of high performance thin‐layer chromatography (HPTLC) immunostaining and ELISA. Human monoclonal antibodies (MoAbs) have been prepared by fusion of human myeloma with peripheral lymphocytes from patients with Graves’ disease. A MoAb, TRMo‐4, reacted strongly and specifically with Gb5. These results suggest that anti‐Forssman antibody may be involved in the pathogenesis of these autoimmune diseases. The detection of anti‐Forssman glycolipid antibody may provide a useful means for clinical diagnosis and therapy.

Original languageEnglish (US)
Pages (from-to)483-488
Number of pages6
JournalClinical & Experimental Immunology
Volume86
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Hashimoto Disease
Graves Disease
Autoantibodies
Forssman Antigen
Antibodies
Glycolipids
Autoimmune Diseases
Chromatography
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Lymphocytes
Serum
Forssman glycolipid
Therapeutics

Keywords

  • Forssman glycolipid
  • Graves' disease
  • Hashimoto's disease
  • autoantibodies
  • autoimmune disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis. / ARIGA, T.; YOSHIDA, T.; MIMORI, T.; Yu, Robert K.

In: Clinical & Experimental Immunology, Vol. 86, No. 3, 01.01.1991, p. 483-488.

Research output: Contribution to journalArticle

@article{5458d8747c454eb39cd56cd4b8ef938c,
title = "Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis",
abstract = "Sera from patients with Graves’ disease and Hashimoto's thyroiditis have been shown to react with the Forssman glycolipid antigen (Gb5) using the techniques of high performance thin‐layer chromatography (HPTLC) immunostaining and ELISA. Human monoclonal antibodies (MoAbs) have been prepared by fusion of human myeloma with peripheral lymphocytes from patients with Graves’ disease. A MoAb, TRMo‐4, reacted strongly and specifically with Gb5. These results suggest that anti‐Forssman antibody may be involved in the pathogenesis of these autoimmune diseases. The detection of anti‐Forssman glycolipid antibody may provide a useful means for clinical diagnosis and therapy.",
keywords = "Forssman glycolipid, Graves' disease, Hashimoto's disease, autoantibodies, autoimmune disease",
author = "T. ARIGA and T. YOSHIDA and T. MIMORI and Yu, {Robert K}",
year = "1991",
month = "1",
day = "1",
doi = "10.1111/j.1365-2249.1991.tb02957.x",
language = "English (US)",
volume = "86",
pages = "483--488",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis

AU - ARIGA, T.

AU - YOSHIDA, T.

AU - MIMORI, T.

AU - Yu, Robert K

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Sera from patients with Graves’ disease and Hashimoto's thyroiditis have been shown to react with the Forssman glycolipid antigen (Gb5) using the techniques of high performance thin‐layer chromatography (HPTLC) immunostaining and ELISA. Human monoclonal antibodies (MoAbs) have been prepared by fusion of human myeloma with peripheral lymphocytes from patients with Graves’ disease. A MoAb, TRMo‐4, reacted strongly and specifically with Gb5. These results suggest that anti‐Forssman antibody may be involved in the pathogenesis of these autoimmune diseases. The detection of anti‐Forssman glycolipid antibody may provide a useful means for clinical diagnosis and therapy.

AB - Sera from patients with Graves’ disease and Hashimoto's thyroiditis have been shown to react with the Forssman glycolipid antigen (Gb5) using the techniques of high performance thin‐layer chromatography (HPTLC) immunostaining and ELISA. Human monoclonal antibodies (MoAbs) have been prepared by fusion of human myeloma with peripheral lymphocytes from patients with Graves’ disease. A MoAb, TRMo‐4, reacted strongly and specifically with Gb5. These results suggest that anti‐Forssman antibody may be involved in the pathogenesis of these autoimmune diseases. The detection of anti‐Forssman glycolipid antibody may provide a useful means for clinical diagnosis and therapy.

KW - Forssman glycolipid

KW - Graves' disease

KW - Hashimoto's disease

KW - autoantibodies

KW - autoimmune disease

UR - http://www.scopus.com/inward/record.url?scp=0025718824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025718824&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2249.1991.tb02957.x

DO - 10.1111/j.1365-2249.1991.tb02957.x

M3 - Article

VL - 86

SP - 483

EP - 488

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 3

ER -